0041 GMT - Investors appear to like the strategic pivot by Ramsay Health Care's new CEO Natalie Davis. Ramsay's share price leaps 15% to its highest level in nearly three months after the company said it is reviewing its majority stake in European private hospital business Ramsay Santé. News of the review comes just days after Ramsay said it has paused investment in expanding its Elysium mental health services business in the U.K. as it concentrates on improving performance. "Board clearly positioning for break-up scenarios, admitting Elysium and Santé have not worked," says Wilsons analyst Shane Storey. Assessing Ramsay's 1H result, Wilsons says activity levels appears to have held up well. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
February 26, 2025 19:41 ET (00:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.